Pharmacokinetics and 48-week Safety and Antiviral Activity of Fosamprenavir-containing Regimens in HIV-infected 2- to 18-year-old Children

BACKGROUND: Pharmacokinetics, safety and antiviral activity of twice-daily fosamprenavir with or without ritonavir were evaluated in 2- to 18-year-old protease inhibitor–naïve and -experienced HIV-1–infected children. METHODS: Serial pharmacokinetic samples were collected at week 2 and predose sampl...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Fortuny, Claudia, Duiculescu, Dan, Cheng, Katharine, Garges, Harmony P., Cotton, Mark, Tamarirt, Desamparados Pérez, Ford, Susan L., Wire, Mary Beth, Givens, Naomi, Ross, Lisa L., Lou, Yu, Perger, Teodora, Sievers, Jörg
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Williams & Wilkins 2014
Konular:
HIV Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3882305/
https://ncbi.nlm.nih.gov/pubmed/23811744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0b013e3182a1126a
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller